131 related articles for article (PubMed ID: 3761747)
1. Antiulcer effect of (-)-cis-2,3-dihydro-3-(4-methylpiperazinylmethyl) -2-phenyl-1,5-benzothiazepin-4-(5H)-one hydrochloride (BTM-1086) in experimental animals.
Yamamoto H; Nakamura Y; Kunoh Y; Ichihara K; Nagasaka M; Asai H
Jpn J Pharmacol; 1986 Jul; 41(3):283-92. PubMed ID: 3761747
[TBL] [Abstract][Full Text] [Related]
2. Effect of elcatonin on experimental gastric and duodenal ulcers.
Ohno H; Noguchi M; Takayanagi N
Jpn J Pharmacol; 1985 Jan; 37(1):67-75. PubMed ID: 4039385
[TBL] [Abstract][Full Text] [Related]
3. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a new potent anti-ulcer and gastric secretory inhibiting agent, (-)-cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5-benzothiazepin-4(5H)-one hydrochloride (BTM-1086), and related compounds.
Ohno S; Izumi K; Mizukoshi K; Kato K; Hori M
Chem Pharm Bull (Tokyo); 1983 May; 31(5):1780-3. PubMed ID: 6616728
[No Abstract] [Full Text] [Related]
5. Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs.
Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
Life Sci; 2001 Nov; 70(1):17-24. PubMed ID: 11764003
[TBL] [Abstract][Full Text] [Related]
6. Effects of (-)-cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl- 1,5-benzothiaze pin-4-(5H)-one hydrochloride (BTM-1086) on ulceration, gastric secretion and mucosal blood flow in experimental animals.
Yamamoto H; Asai H
Chem Pharm Bull (Tokyo); 1986 Sep; 34(9):3844-53. PubMed ID: 3815606
[No Abstract] [Full Text] [Related]
7. Specificity in the pharmacological actions of optical isomers of cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5- benzothiazepin-4(5H)-one (BTM).
Yamamoto H; Nakamura Y; Nagasaka M; Asai H
Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3419-24. PubMed ID: 3427721
[No Abstract] [Full Text] [Related]
8. Effects of MCI-727, a new antiulcer agent, on various gastric and duodenal lesions in experimental animals.
Yamazaki S; Kawamura M; Kitsukawa M; Ando K; Nitta I; Tobe A; Okabe S
Jpn J Pharmacol; 1991 Apr; 55(4):415-24. PubMed ID: 1886287
[TBL] [Abstract][Full Text] [Related]
9. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration.
Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S
Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169
[TBL] [Abstract][Full Text] [Related]
10. Competitive enzyme immunoassay for anti-ulcer agent, (-)-cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5- benzothiazepin-4(5H)-one hydrochloride (BTM-1086).
Asano T; Okumura T; Hirano K; Adachi T; Sugiura M
Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4238-43. PubMed ID: 3549012
[No Abstract] [Full Text] [Related]
11. Anti-ulcer activity of cromakalim (BRL 34915), a potassium-channel opener, against experimentally induced gastric and duodenal ulcers in rats and guinea-pigs.
Goswami S; Jain S; Santani D
J Pharm Pharmacol; 1997 Feb; 49(2):195-9. PubMed ID: 9055194
[TBL] [Abstract][Full Text] [Related]
12. cis(-)-2,3-Dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5- benzothiazepin-4(5H)-one monohydrochloride and its butylbromide as M1-receptor antagonists.
Takayanagi I; Konno F; Akaike M; Nibori Y; Yamura S
Gen Pharmacol; 1987; 18(1):91-3. PubMed ID: 3557056
[TBL] [Abstract][Full Text] [Related]
13. Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats.
Yamasaki K; Ishiyama H; Imaizumi T; Kanbe T; Yabuuchi Y
Jpn J Pharmacol; 1989 Apr; 49(4):441-8. PubMed ID: 2542684
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new benzimidazole derivative, NC-1300-O-3, on gastric secretion and gastroduodenal lesions in rats.
Okabe S; Akimoto Y; Yamasaki S; Kuwahara K
Jpn J Pharmacol; 1991 Apr; 55(4):477-91. PubMed ID: 1832198
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of tiquizium bromide (HSR-902) as an antiulcer agent].
Morikawa K; Aratani T; Mizutani F; Kato H; Ito Y
Nihon Yakurigaku Zasshi; 1987 Nov; 90(5):273-83. PubMed ID: 2895053
[TBL] [Abstract][Full Text] [Related]
16. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
[TBL] [Abstract][Full Text] [Related]
17. Gastric and duodenal anti-ulcer activity of SKF 38393, a dopamine D1-receptor agonist in rats.
Desai JK; Goyal RK; Parmar NS
J Pharm Pharmacol; 1995 Sep; 47(9):734-8. PubMed ID: 8583385
[TBL] [Abstract][Full Text] [Related]
18. Effects of cimetidine, a histamine H2-receptor antagonist, on various experimental gastric and duodenal ulcers.
Okabe S; Takeuchi K; Urushidani T; Takagi K
Am J Dig Dis; 1977 Aug; 22(8):677-84. PubMed ID: 18007
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity.
Al-Said MS; Ageel AM; Parmar NS; Tariq M
J Ethnopharmacol; 1986 Mar; 15(3):271-8. PubMed ID: 3724207
[TBL] [Abstract][Full Text] [Related]
20. Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats.
Yamamoto O; Okada Y; Okabe S
Dig Dis Sci; 1984 May; 29(5):394-401. PubMed ID: 6714055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
